{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:15:17Z","timestamp":1793196917900,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL145228"],"award-info":[{"award-number":["HL145228"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL087123"],"award-info":[{"award-number":["HL087123"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL159012"],"award-info":[{"award-number":["HL159012"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL159012"],"award-info":[{"award-number":["HL159012"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA076292"],"award-info":[{"award-number":["P30 CA076292"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-024-01115-7","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T10:02:54Z","timestamp":1725616974000},"page":"1736-1755","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2334-4685","authenticated-orcid":false,"given":"Santosh R.","family":"Sukka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0561-1145","authenticated-orcid":false,"given":"Patrick B.","family":"Ampomah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lancia N. F.","family":"Darville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ngai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6044-914X","authenticated-orcid":false,"given":"Xiaobo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kuriakose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9200-5068","authenticated-orcid":false,"given":"Jinjun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3818-1762","authenticated-orcid":false,"given":"John M.","family":"Koomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8006-3228","authenticated-orcid":false,"given":"Robert H.","family":"McCusker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3429-1515","authenticated-orcid":false,"given":"Ira","family":"Tabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"1115_CR1","doi-asserted-by":"publisher","first-page":"107879","DOI":"10.1016\/j.pharmthera.2021.107879","volume":"227","author":"D Panigrahy","year":"2021","unstructured":"Panigrahy, D., Gilligan, M. M., Serhan, C. N. & Kashfi, K. Resolution of inflammation: an organizing principle in biology and medicine. Pharmacol. Ther. 227, 107879 (2021).","journal-title":"Pharmacol. Ther."},{"key":"1115_CR2","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","volume":"140","author":"C Nathan","year":"2010","unstructured":"Nathan, C. & Ding, A. Nonresolving inflammation. Cell 140, 871\u2013882 (2010).","journal-title":"Cell"},{"key":"1115_CR3","doi-asserted-by":"publisher","first-page":"a008748","DOI":"10.1101\/cshperspect.a008748","volume":"5","author":"A Hochreiter-Hufford","year":"2013","unstructured":"Hochreiter-Hufford, A. & Ravichandran, K. S. Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harb. Perspect. Biol. 5, a008748 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1115_CR4","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.immuni.2019.04.018","volume":"50","author":"S Morioka","year":"2019","unstructured":"Morioka, S., Maueroder, C. & Ravichandran, K. S. Living on the edge: efferocytosis at the interface of homeostasis and pathology. Immunity 50, 1149\u20131162 (2019).","journal-title":"Immunity"},{"key":"1115_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","volume":"20","author":"AC Doran","year":"2020","unstructured":"Doran, A. C., Yurdagul, A. Jr. & Tabas, I. Efferocytosis in health and disease. Nat. Rev. Immunol. 20, 254\u2013267 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1115_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev-cellbio-111315-125315","volume":"33","author":"PM Henson","year":"2017","unstructured":"Henson, P. M. Cell removal: efferocytosis. Annu. Rev. Cell Dev. Biol. 33, 127\u2013144 (2017).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"1115_CR7","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1253\/circj.CJ-16-0924","volume":"80","author":"MF Linton","year":"2016","unstructured":"Linton, M. F. et al. Macrophage apoptosis and efferocytosis in the pathogenesis of atherosclerosis. Circ. J. 80, 2259\u20132268 (2016).","journal-title":"Circ. J."},{"key":"1115_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/CIRCULATIONAHA.116.025684","volume":"135","author":"Y Kojima","year":"2017","unstructured":"Kojima, Y., Weissman, I. L. & Leeper, N. J. The role of efferocytosis in atherosclerosis. Circulation 135, 476\u2013489 (2017).","journal-title":"Circulation"},{"key":"1115_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.immuni.2009.06.018","volume":"31","author":"N A-Gonzalez","year":"2009","unstructured":"A-Gonzalez, N. et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31, 245\u2013258 (2009).","journal-title":"Immunity"},{"key":"1115_CR10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.cmet.2020.01.001","volume":"31","author":"A Yurdagul Jr.","year":"2020","unstructured":"Yurdagul, A. Jr. et al. Macrophage metabolism of apoptotic cell-derived arginine promotes continual efferocytosis and resolution of injury. Cell Metab. 31, 518\u2013533 (2020).","journal-title":"Cell Metab."},{"key":"1115_CR11","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1161\/ATVBAHA.120.315622","volume":"41","author":"A Yurdagul Jr.","year":"2021","unstructured":"Yurdagul, A. Jr. et al. ODC (ornithine decarboxylase)-dependent putrescine synthesis maintains MerTK (MER tyrosine-protein kinase) expression to drive resolution. Arterioscler. Thromb. Vasc. Biol. 41, e144\u2013e159 (2021).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1115_CR12","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.cmet.2021.10.015","volume":"33","author":"BD Gerlach","year":"2021","unstructured":"Gerlach, B. D. et al. Efferocytosis induces macrophage proliferation to help resolve tissue injury. Cell Metab. 33, 2445\u20132463 (2021).","journal-title":"Cell Metab."},{"key":"1115_CR13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s42255-022-00551-7","volume":"4","author":"PB Ampomah","year":"2022","unstructured":"Ampomah, P. B. et al. Macrophages use apoptotic cell-derived methionine and DNMT3A during efferocytosis to promote tissue resolution. Nat. Metab. 4, 444\u2013457 (2022).","journal-title":"Nat. Metab."},{"key":"1115_CR14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cmet.2018.12.004","volume":"29","author":"S Zhang","year":"2018","unstructured":"Zhang, S. et al. Efferocytosis fuels requirements of fatty acid oxidation and the electron transport chain to polarize macrophages for tissue repair. Cell Metab. 29, 443\u2013456 (2018).","journal-title":"Cell Metab."},{"key":"1115_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1440-1711.2003.t01-1-01177.x","volume":"81","author":"JR Moffett","year":"2003","unstructured":"Moffett, J. R. & Namboodiri, M. A. Tryptophan and the immune response. Immunol. Cell Biol. 81, 247\u2013265 (2003).","journal-title":"Immunol. Cell Biol."},{"key":"1115_CR16","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1074\/jbc.M110.172403","volume":"286","author":"SM Pillai","year":"2011","unstructured":"Pillai, S. M. & Meredith, D. SLC36A4 (hPAT4) is a high affinity amino acid transporter when expressed in Xenopus laevis oocytes. J. Biol. Chem. 286, 2455\u20132460 (2011).","journal-title":"J. Biol. Chem."},{"key":"1115_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/acel.12561","volume":"16","author":"P Shang","year":"2017","unstructured":"Shang, P. et al. The amino acid transporter SLC36A4 regulates the amino acid pool in retinal pigmented epithelial cells and mediates the mechanistic target of rapamycin, complex 1 signaling. Aging Cell 16, 349\u2013359 (2017).","journal-title":"Aging Cell"},{"key":"1115_CR18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/sj.cdd.4402242","volume":"15","author":"SY Park","year":"2008","unstructured":"Park, S. Y. et al. Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ. 15, 192\u2013201 (2008).","journal-title":"Cell Death Differ."},{"key":"1115_CR19","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1091\/mbc.e13-04-0212","volume":"25","author":"RS Flannagan","year":"2014","unstructured":"Flannagan, R. S., Canton, J., Furuya, W., Glogauer, M. & Grinstein, S. The phosphatidylserine receptor TIM4 utilizes integrins as coreceptors to effect phagocytosis. Mol. Biol. Cell 25, 1511\u20131522 (2014).","journal-title":"Mol. Biol. Cell"},{"key":"1115_CR20","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1083\/jcb.201711175","volume":"217","author":"AP Williamson","year":"2018","unstructured":"Williamson, A. P. & Vale, R. D. Spatial control of Draper receptor signaling initiates apoptotic cell engulfment. J. Cell Biol. 217, 3977\u20133992 (2018).","journal-title":"J. Cell Biol."},{"key":"1115_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19272-0","volume":"11","author":"H Moon","year":"2020","unstructured":"Moon, H. et al. Crbn modulates calcium influx by regulating Orai1 during efferocytosis. Nat. Commun. 11, 5489 (2020).","journal-title":"Nat. Commun."},{"key":"1115_CR22","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1111\/febs.16086","volume":"289","author":"MT Pallotta","year":"2022","unstructured":"Pallotta, M. T. et al. Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme. FEBS J. 289, 6099\u20136118 (2022).","journal-title":"FEBS J."},{"key":"1115_CR23","doi-asserted-by":"publisher","first-page":"17707","DOI":"10.1016\/S0021-9258(19)47429-2","volume":"266","author":"T Yoshimori","year":"1991","unstructured":"Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M. & Tashiro, Y. Bafilomycin A1, a specific inhibitor of vacuolar-type H+-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J. Biol. Chem. 266, 17707\u201317712 (1991).","journal-title":"J. Biol. Chem."},{"key":"1115_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature10340","volume":"477","author":"D Park","year":"2011","unstructured":"Park, D. et al. Continued clearance of apoptotic cells critically depends on the phagocyte Ucp2 protein. Nature 477, 220\u2013224 (2011).","journal-title":"Nature"},{"key":"1115_CR25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1158\/1535-7163.MCT-09-0628","volume":"9","author":"HK Koblish","year":"2010","unstructured":"Koblish, H. K. et al. Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors. Mol. Cancer Ther. 9, 489\u2013498 (2010).","journal-title":"Mol. Cancer Ther."},{"key":"1115_CR26","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1182\/blood-2009-09-246124","volume":"115","author":"X Liu","year":"2010","unstructured":"Liu, X. et al. Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity. Blood 115, 3520\u20133530 (2010).","journal-title":"Blood"},{"key":"1115_CR27","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/nri2214","volume":"7","author":"KS Ravichandran","year":"2007","unstructured":"Ravichandran, K. S. & Lorenz, U. Engulfment of apoptotic cells: signals for a good meal. Nat. Rev. Immunol. 7, 964\u2013974 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"1115_CR28","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.immuni.2018.07.015","volume":"49","author":"JD Proto","year":"2018","unstructured":"Proto, J. D. et al. Regulatory T cells promote macrophage efferocytosis during inflammation resolution. Immunity 49, 666\u2013677.e666 (2018).","journal-title":"Immunity"},{"key":"1115_CR29","doi-asserted-by":"publisher","first-page":"44490","DOI":"10.1074\/jbc.M405144200","volume":"279","author":"AM Vall\u00e9s","year":"2004","unstructured":"Vall\u00e9s, A. M., Beuvin, M. & Boyer, B. Activation of Rac1 by paxillin\u2013Crk\u2013DOCK180 signaling complex is antagonized by Rap1 in migrating NBT-II cells. J. Biol. Chem. 279, 44490\u201344496 (2004).","journal-title":"J. Biol. Chem."},{"key":"1115_CR30","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1172\/JCI1112","volume":"101","author":"VA Fadok","year":"1998","unstructured":"Fadok, V. A. et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF-\u03b2, PGE2, and PAF. J. Clin. Invest. 101, 890\u2013898 (1998).","journal-title":"J. Clin. Invest."},{"key":"1115_CR31","doi-asserted-by":"publisher","first-page":"eaaf9794","DOI":"10.1126\/science.aaf9794","volume":"357","author":"I Cervenka","year":"2017","unstructured":"Cervenka, I., Agudelo, L. Z. & Ruas, J. L. Kynurenines: tryptophan\u2019s metabolites in exercise, inflammation, and mental health. Science 357, eaaf9794 (2017).","journal-title":"Science"},{"key":"1115_CR32","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.4049\/jimmunol.0902866","volume":"184","author":"RA Navarro-Xavier","year":"2010","unstructured":"Navarro-Xavier, R. A. et al. A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties. J. Immunol. 184, 1516\u20131525 (2010).","journal-title":"J. Immunol."},{"key":"1115_CR33","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","volume":"55","author":"K Hezaveh","year":"2022","unstructured":"Hezaveh, K. et al. Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. Immunity 55, 324\u2013340 (2022).","journal-title":"Immunity"},{"key":"1115_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17750-z","volume":"11","author":"LF Campesato","year":"2020","unstructured":"Campesato, L. F. et al. Blockade of the AHR restricts a Treg\u2013macrophage suppressive axis induced by l-kynurenine. Nat. Commun. 11, 4011 (2020).","journal-title":"Nat. Commun."},{"key":"1115_CR35","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3389\/fimmu.2014.00551","volume":"5","author":"NT Nguyen","year":"2014","unstructured":"Nguyen, N. T. et al. Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research. Front Immunol. 5, 551 (2014).","journal-title":"Front Immunol."},{"key":"1115_CR36","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","volume":"185","author":"JD Mezrich","year":"2010","unstructured":"Mezrich, J. D. et al. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J. Immunol. 185, 3190\u20133198 (2010).","journal-title":"J. Immunol."},{"key":"1115_CR37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature10491","volume":"478","author":"CA Opitz","year":"2011","unstructured":"Opitz, C. A. et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478, 197\u2013203 (2011).","journal-title":"Nature"},{"key":"1115_CR38","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.fob.2014.09.003","volume":"4","author":"N Tsuji","year":"2014","unstructured":"Tsuji, N. et al. The activation mechanism of the aryl hydrocarbon receptor (AhR) by molecular chaperone HSP90. FEBS Open Bio. 4, 796\u2013803 (2014).","journal-title":"FEBS Open Bio."},{"key":"1115_CR39","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1124\/mol.105.021832","volume":"69","author":"SH Kim","year":"2006","unstructured":"Kim, S. H. et al. Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol. Pharmacol. 69, 1871\u20131878 (2006).","journal-title":"Mol. Pharmacol."},{"key":"1115_CR40","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bbrc.2008.07.156","volume":"375","author":"CF Vogel","year":"2008","unstructured":"Vogel, C. F., Goth, S. R., Dong, B., Pessah, I. N. & Matsumura, F. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem. Biophys. Res. Commun. 375, 331\u2013335 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1115_CR41","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1126\/science.1852076","volume":"252","author":"EC Hoffman","year":"1991","unstructured":"Hoffman, E. C. et al. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252, 954\u2013958 (1991).","journal-title":"Science"},{"key":"1115_CR42","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1242\/jcs.049569","volume":"122","author":"SY Park","year":"2009","unstructured":"Park, S. Y. et al. Stabilin-1 mediates phosphatidylserine-dependent clearance of cell corpses in alternatively activated macrophages. J. Cell Sci. 122, 3365\u20133373 (2009).","journal-title":"J. Cell Sci."},{"key":"1115_CR43","doi-asserted-by":"publisher","first-page":"18623","DOI":"10.1074\/jbc.273.29.18623","volume":"273","author":"MF Favata","year":"1998","unstructured":"Favata, M. F. et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623\u201318632 (1998).","journal-title":"J. Biol. Chem."},{"key":"1115_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1379\/1466-1268(2004)009<0004:COHSPA>2.0.CO;2","volume":"9","author":"MB Cox","year":"2004","unstructured":"Cox, M. B. & Miller, C. A. III Cooperation of heat shock protein 90 and p23 in aryl hydrocarbon receptor signaling. Cell Stress Chaperones 9, 4\u201320 (2004).","journal-title":"Cell Stress Chaperones"},{"key":"1115_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bcp.2018.03.015","volume":"152","author":"B Pappas","year":"2018","unstructured":"Pappas, B. et al. p23 protects the human aryl hydrocarbon receptor from degradation via a heat shock protein 90-independent mechanism. Biochem. Pharmacol. 152, 34\u201344 (2018).","journal-title":"Biochem. Pharmacol."},{"key":"1115_CR46","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1001\/jama.2022.5218","volume":"327","author":"L Raber","year":"2022","unstructured":"Raber, L. et al. Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI Randomized Clinical Trial. JAMA 327, 1771\u20131781 (2022).","journal-title":"JAMA"},{"key":"1115_CR47","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.jcmg.2022.03.002","volume":"15","author":"SJ Nicholls","year":"2022","unstructured":"Nicholls, S. J. et al. Effect of evolocumab on coronary plaque phenotype and burden in statin-treated patients following myocardial infarction. JACC Cardiovasc. Imaging 15, 1308\u20131321 (2022).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"1115_CR48","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/CIRCRESAHA.119.316461","volume":"127","author":"M Sharma","year":"2020","unstructured":"Sharma, M. et al. Regulatory T cells license macrophage pro-resolving functions during atherosclerosis regression. Circ. Res. 127, 335\u2013353 (2020).","journal-title":"Circ. Res."},{"key":"1115_CR49","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41590-018-0107-1","volume":"19","author":"R Shinde","year":"2018","unstructured":"Shinde, R. et al. Apoptotic cell-induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans. Nat. Immunol. 19, 571\u2013582 (2018).","journal-title":"Nat. Immunol."},{"key":"1115_CR50","doi-asserted-by":"publisher","first-page":"e2304690","DOI":"10.1002\/advs.202304690","volume":"11","author":"DS Koenis","year":"2023","unstructured":"Koenis, D. S., de Matteis, R., Rajeeve, V., Cutillas, P. & Dalli, J. Efferocyte-derived MCTRs metabolically prime macrophages for continual efferocytosis via Rac1-mediated activation of glycolysis. Adv. Sci. 11, e2304690 (2023).","journal-title":"Adv. Sci."},{"key":"1115_CR51","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.4049\/jimmunol.175.9.5601","volume":"175","author":"AL Mellor","year":"2005","unstructured":"Mellor, A. L. et al. Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN type 1 signaling. J. Immunol. 175, 5601\u20135605 (2005).","journal-title":"J. Immunol."},{"key":"1115_CR52","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1073\/pnas.1117736109","volume":"109","author":"B Ravishankar","year":"2012","unstructured":"Ravishankar, B. et al. Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase. Proc. Natl Acad. Sci. USA 109, 3909\u20133914 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1115_CR53","doi-asserted-by":"publisher","first-page":"10774","DOI":"10.1073\/pnas.1504276112","volume":"112","author":"B Ravishankar","year":"2015","unstructured":"Ravishankar, B. et al. The amino acid sensor GCN2 inhibits inflammatory responses to apoptotic cells promoting tolerance and suppressing systemic autoimmunity. Proc. Natl Acad. Sci. USA 112, 10774\u201310779 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1115_CR54","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ccell.2018.02.005","volume":"33","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. Tumor-repopulating cells induce PD-1 expression in CD8+T cells by transferring kynurenine and AhR activation. Cancer Cell 33, 480\u2013494 (2018).","journal-title":"Cancer Cell"},{"key":"1115_CR55","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/toxsci\/kfh228","volume":"82","author":"Z Tan","year":"2004","unstructured":"Tan, Z., Huang, M., Puga, A. & Xia, Y. A critical role for MAP kinases in the control of Ah receptor complex activity. Toxicol. Sci. 82, 80\u201387 (2004).","journal-title":"Toxicol. Sci."},{"key":"1115_CR56","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cmet.2015.07.004","volume":"22","author":"S Metghalchi","year":"2015","unstructured":"Metghalchi, S. et al. Indoleamine 2,3-dioxygenase fine-tunes immune homeostasis in atherosclerosis and colitis through repression of interleukin-10 production. Cell Metab. 22, 460\u2013471 (2015).","journal-title":"Cell Metab."},{"key":"1115_CR57","doi-asserted-by":"publisher","first-page":"13033","DOI":"10.1073\/pnas.1517820112","volume":"112","author":"JE Cole","year":"2015","unstructured":"Cole, J. E. et al. Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development. Proc. Natl Acad. Sci. USA 112, 13033\u201313038 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1115_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/joim.13142","volume":"289","author":"R Baumgartner","year":"2021","unstructured":"Baumgartner, R. et al. Evidence that a deviation in the kynurenine pathway aggravates atherosclerotic disease in humans. J. Intern Med 289, 53\u201368 (2021).","journal-title":"J. Intern Med"},{"key":"1115_CR59","doi-asserted-by":"publisher","first-page":"154874","DOI":"10.1016\/j.phymed.2023.154874","volume":"116","author":"L Yang","year":"2023","unstructured":"Yang, L., Zheng, C., Xia, Y. F., Dai, Y. & Wei, Z. F. 3,3\u2032-diindolylmethane enhances macrophage efferocytosis and subsequently relieves visceral pain via the AhR\/Nrf2\/Arg-1-mediated arginine metabolism pathway. Phytomedicine 116, 154874 (2023).","journal-title":"Phytomedicine"},{"key":"1115_CR60","doi-asserted-by":"publisher","first-page":"104047","DOI":"10.1016\/j.cellimm.2020.104047","volume":"349","author":"LX Tian","year":"2020","unstructured":"Tian, L. X. et al. Cytochrome P450 1A1 enhances arginase-1 expression, which reduces LPS-induced mouse peritonitis by targeting JAK1\/STAT6. Cell Immunol. 349, 104047 (2020).","journal-title":"Cell Immunol."},{"key":"1115_CR61","first-page":"4763","volume":"20","author":"K Zhu","year":"2019","unstructured":"Zhu, K. et al. Aryl hydrocarbon receptor pathway: role, regulation and intervention in atherosclerosis therapy. Mol. Med. Rep. 20, 4763\u20134773 (2019).","journal-title":"Mol. Med. Rep."},{"key":"1115_CR62","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1161\/ATVBAHA.110.220202","volume":"31","author":"D Wu","year":"2011","unstructured":"Wu, D. et al. Activation of aryl hydrocarbon receptor induces vascular inflammation and promotes atherosclerosis in apolipoprotein E\u2212\/\u2212 mice. Arterioscler. Thromb. Vasc. Biol. 31, 1260\u20131267 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1115_CR63","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41573-022-00470-y","volume":"21","author":"P Mehrotra","year":"2022","unstructured":"Mehrotra, P. & Ravichandran, K. S. Drugging the efferocytosis process: concepts and opportunities. Nat. Rev. Drug Discov. 21, 601\u2013620 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1115_CR64","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1016\/j.cell.2022.11.029","volume":"185","author":"S Morioka","year":"2022","unstructured":"Morioka, S. et al. Chimeric efferocytic receptors improve apoptotic cell clearance and alleviate inflammation. Cell 185, 4887\u20134903 (2022).","journal-title":"Cell"},{"key":"1115_CR65","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature18935","volume":"536","author":"Y Kojima","year":"2016","unstructured":"Kojima, Y. et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature 536, 86\u201390 (2016).","journal-title":"Nature"},{"key":"1115_CR66","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41565-019-0619-3","volume":"15","author":"AM Flores","year":"2020","unstructured":"Flores, A. M. et al. Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis. Nat. Nanotechnol. 15, 154\u2013161 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"1115_CR67","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13287-023-03443-z","volume":"14","author":"MV Schrodt","year":"2023","unstructured":"Schrodt, M. V. et al. Efferocytosis of viable versus heat-inactivated MSC induces human monocytes to distinct immunosuppressive phenotypes. Stem Cell Res. Ther. 14, 206 (2023).","journal-title":"Stem Cell Res. Ther."},{"key":"1115_CR68","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/ajcn\/nqac170","volume":"116","author":"Q Li","year":"2022","unstructured":"Li, Q. et al. Associations between plasma tryptophan and indole-3-propionic acid levels and mortality in patients with coronary artery disease. Am. J. Clin. Nutr. 116, 1070\u20131077 (2022).","journal-title":"Am. J. Clin. Nutr."},{"key":"1115_CR69","first-page":"314","volume":"147","author":"E Yu","year":"2017","unstructured":"Yu, E. et al. Increases in plasma tryptophan are inversely associated with incident cardiovascular disease in the Prevenci\u00f3n con Dieta Mediterr\u00e1nea (PREDIMED) study. J. Nutr. 147, 314\u2013322 (2017).","journal-title":"J. Nutr."},{"key":"1115_CR70","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/eci.12402","volume":"45","author":"C Murr","year":"2015","unstructured":"Murr, C. et al. Low serum tryptophan predicts higher mortality in cardiovascular disease. Eur. J. Clin. Invest 45, 247\u2013254 (2015).","journal-title":"Eur. J. Clin. Invest"},{"key":"1115_CR71","doi-asserted-by":"publisher","first-page":"115540","DOI":"10.1016\/j.biopha.2023.115540","volume":"167","author":"H Qiu","year":"2023","unstructured":"Qiu, H. et al. Efferocytosis: an accomplice of cancer immune escape. Biomed. Pharmacother. 167, 115540 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"1115_CR72","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1158\/0008-5472.CAN-18-1106","volume":"79","author":"TA Werfel","year":"2019","unstructured":"Werfel, T. A. et al. Treatment-induced tumor cell apoptosis and secondary necrosis drive tumor progression in the residual tumor microenvironment through MerTK and IDO1. Cancer Res. 79, 171\u2013182 (2019).","journal-title":"Cancer Res."},{"key":"1115_CR73","doi-asserted-by":"publisher","first-page":"100116","DOI":"10.1016\/j.bbih.2020.100116","volume":"7","author":"LA Wetzel","year":"2020","unstructured":"Wetzel, L. A., Hurtado, M., MacDowell Kaswan, Z. A., McCusker, R. H. & Steelman, A. J. Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG(35-55)-induced experimental autoimmune encephalomyelitis. Brain Behav. Immun. Health 7, 100116 (2020).","journal-title":"Brain Behav. Immun. Health"},{"key":"1115_CR74","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cell.2017.08.041","volume":"171","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Mitochondrial fission promotes the continued clearance of apoptotic cells by macrophages. Cell 171, 331\u2013345 (2017).","journal-title":"Cell"},{"key":"1115_CR75","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1007\/s00216-011-5436-y","volume":"401","author":"W Zhu","year":"2011","unstructured":"Zhu, W. et al. Quantitative profiling of tryptophan metabolites in serum, urine, and cell culture supernatants by liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 401, 3249\u20133261 (2011).","journal-title":"Anal. Bioanal. Chem."},{"key":"1115_CR76","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s42255-023-00736-8","volume":"5","author":"M Schilperoort","year":"2023","unstructured":"Schilperoort, M., Ngai, D., Katerelos, M., Power, D. A. & Tabas, I. PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages. Nat. Metab. 5, 431\u2013444 (2023).","journal-title":"Nat. Metab."},{"key":"1115_CR77","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s42255-023-00921-9","volume":"5","author":"D Ngai","year":"2023","unstructured":"Ngai, D., Schilperoort, M. & Tabas, I. Efferocytosis-induced lactate enables the proliferation of pro-resolving macrophages to mediate tissue repair. Nat. Metab. 5, 2206\u20132219 (2023).","journal-title":"Nat. Metab."}],"updated-by":[{"DOI":"10.1038\/s42255-024-01142-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000}}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-024-01115-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-024-01115-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-024-01115-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T23:03:28Z","timestamp":1727219008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-024-01115-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":77,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["1115"],"URL":"https:\/\/doi.org\/10.1038\/s42255-024-01115-7","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s42255-024-01142-4","asserted-by":"object"}]},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"assertion":[{"value":"3 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s42255-024-01142-4","URL":"https:\/\/doi.org\/10.1038\/s42255-024-01142-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}